These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 28228120)

  • 21. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of computed tomographic angiography and echocardiography in predicting left atrial appendage thrombosis in patients with non-valvular atrial fibrillation.
    Wu X; Sun F; Ma S; Wang Z; Xu S
    Cardiovasc J Afr; 2023 Sep-Oct 23; 34(4):231-236. PubMed ID: 36383152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left atrial appendage thrombi relate to easily accessible clinical parameters in patients undergoing atrial fibrillation transcatheter ablation: A multicenter study.
    Anselmino M; Garberoglio L; Gili S; Bertaglia E; Stabile G; Marazzi R; Themistoclakis S; Solimene F; Frea S; Grosso Marra W; Morello M; Scaglione M; De Ponti R; Gaita F
    Int J Cardiol; 2017 Aug; 241():218-222. PubMed ID: 28413114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new therapeutic strategy for electrical cardioversion of atrial fibrillation.
    de Luca I; Sorino M; Del Salvatore B; de Luca L
    Ital Heart J; 2001 Nov; 2(11):831-40. PubMed ID: 11770868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incremental diagnostic role of left atrial strain analysis in thrombotic risk assessment of nonvalvular atrial fibrillation patients planned for electrical cardioversion.
    Sonaglioni A; Lombardo M; Nicolosi GL; Rigamonti E; Anzà C
    Int J Cardiovasc Imaging; 2021 May; 37(5):1539-1550. PubMed ID: 33389359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation.
    Scherr D; Dalal D; Chilukuri K; Dong J; Spragg D; Henrikson CA; Nazarian S; Cheng A; Berger RD; Abraham TP; Calkins H; Marine JE
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):379-84. PubMed ID: 19017348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients: a prospective study with a 1-year follow-up.
    de Luca I; Sorino M; De Luca L; Colonna P; Del Salvatore B; Corlianò L
    Int J Cardiol; 2005 Jul; 102(3):447-54. PubMed ID: 16004890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of left atrial appendage function and thrombi in patients with atrial fibrillation: from transthoracic to real time 3D transesophageal echocardiography.
    Dentamaro I; Vestito D; Michelotto E; De Santis D; Ostuni V; Cadeddu C; Colonna P
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):491-498. PubMed ID: 27853971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atrial fibrillation patients with CHA2DS2-VASc >1 benefit from oral anticoagulation prior to cardioversion.
    Själander S; Svensson PJ; Friberg L
    Int J Cardiol; 2016 Jul; 215():360-3. PubMed ID: 27128562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the CHA2DS2-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants?
    Michalska A; Gorczyca I; Chrapek M; Kapłon-Cieślicka A; Uziębło-Życzkowska B; Starzyk K; Jelonek O; Budnik M; Gawałko M; Krzesiński P; Jurek A; Scisło P; Kochanowski J; Kiliszek M; Gielerak G; Filipiak KJ; Opolski G; Wożakowska-Kapłon B
    Medicine (Baltimore); 2020 Jun; 99(25):e20570. PubMed ID: 32569181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardioversion of atrial fibrillation in a real-world setting: non-vitamin K antagonist oral anticoagulants ensure a fast and safe strategy compared to warfarin.
    Frederiksen AS; Albertsen AE; Christesen AMS; Vinter N; Frost L; Møller DS
    Europace; 2018 Jul; 20(7):1078-1085. PubMed ID: 28655151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk stratification of patients with left atrial appendage thrombus prior to catheter ablation of atrial fibrillation: An approach towards an individualized use of transesophageal echocardiography.
    Gunawardene MA; Dickow J; Schaeffer BN; Akbulak RÖ; Lemoine MD; Nührich JM; Jularic M; Sinning C; Eickholt C; Meyer C; Moser JM; Hoffmann BA; Willems S
    J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1127-1136. PubMed ID: 28635023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study.
    Black IW; Fatkin D; Sagar KB; Khandheria BK; Leung DY; Galloway JM; Feneley MP; Walsh WF; Grimm RA; Stollberger C
    Circulation; 1994 Jun; 89(6):2509-13. PubMed ID: 8205657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation.
    Lurie A; Wang J; Hinnegan KJ; McIntyre WF; Belley-Côté EP; Amit G; Healey JS; Connolly SJ; Wong JA
    J Am Coll Cardiol; 2021 Jun; 77(23):2875-2886. PubMed ID: 34112315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low vitamin D levels predict left atrial thrombus in nonvalvular atrial fibrillation.
    Çakır OM
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(7):1152-1160. PubMed ID: 32456946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of intracardiac thrombus formation prior to electrical cardioversion in respect to the mode of oral anticoagulation.
    Schaeffer B; Rüden L; Salzbrunn T; Pinnschmidt HO; Akbulak RÖ; Moser JM; Jularic M; Meyer C; Eickholt C; Sultan A; Lüker J; Steven D; Willems S; Hoffmann BA
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):537-547. PubMed ID: 29377448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardioversion in patients with atrial fibrillation and left atrial thrombi on initial transesophageal echocardiography: should transesophageal echocardiography be repeated before elective cardioversion? A cost-effectiveness analysis.
    Seto TB; Taira DA; Manning WJ
    J Am Soc Echocardiogr; 1999 Jun; 12(6):508-16. PubMed ID: 10359923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is CHA
    de Souza MV; de Fátima Dos Santos Teixeira P; Vaisman M; Xavier SS
    Int J Cardiol; 2017 Feb; 228():919-925. PubMed ID: 27912200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis.
    Merino JL; Lip GYH; Heidbuchel H; Cohen AA; De Caterina R; de Groot JR; Ezekowitz MD; Le Heuzey JY; Themistoclakis S; Jin J; Melino M; Winters SM; Merkely B; Goette A
    Europace; 2019 Nov; 21(11):1633-1638. PubMed ID: 31436835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.